rxstatShortages › Heparin

Heparin shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Heparin is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 of 11
Reports on file
51

Reports by product

Anticipated
HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
2UNIT · SOLUTION · PFIZER CANADA ULC
DIN 01990748 · Disruption of the manufacture of the drug.
Resolved
HEPARIN SODIUM INJECTION, USP
10000UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02392453 · ended Jun 1, 2025 · Disruption of the manufacture of the drug.
Avoided
HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
2UNIT · SOLUTION · PFIZER CANADA ULC
DIN 01990748 · ended May 20, 2025 · Disruption of the manufacture of the drug.
Resolved
HEPARIN SODIUM INJECTION, USP
10000UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02264307 · ended May 13, 2025 · Disruption of the manufacture of the drug.
Resolved
HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
2UNIT · SOLUTION · PFIZER CANADA ULC
DIN 01990748 · ended Jan 31, 2025 · Disruption of the manufacture of the drug.
Resolved
HEPARIN SODIUM INJECTION, USP
1000UNIT · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02264315 · ended Jan 10, 2025 · Other (Please describe in comments)
Resolved
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
1000UNIT · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02303086 · ended Jul 29, 2024 · Disruption of the manufacture of the drug.
Discontinued
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
10000UNIT · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02303108
Resolved
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
10000UNIT · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02303108 · ended May 17, 2024 · Disruption of the manufacture of the drug.
Resolved
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
1000UNIT · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02303086 · ended Feb 26, 2024 · Disruption of the manufacture of the drug.
Discontinued
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
10000UNIT · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02303108
Resolved
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
10000UNIT · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02303108 · ended Oct 18, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 51 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Heparin to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Heparin is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AB).

Recent changes

Common questions

When will Heparin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Heparin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

All antithrombotic agents shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.